Cases
-
Latest cases
New Comprehensive Analysis of PBM-Affiliated Pharmacy Reimbursements Shows FTC Interim Reports Reached Flawed Conclusions Based on a Small, Non-Representative Sample of Drugs
-
Latest cases
Compass Lexecon Client DePuy Synthes Prevails in Patent Infringement Litigation
Court agrees with the testimony of Compass Lexecon affiliate Peter Rossi
-
Latest cases
Compass Lexecon Client Neist Media Prevails in Lanham Act Dispute
Court Agrees with Expert Opinions of Compass Lexecon Executive Vice President Niall MacMenamin
-
Latest cases
Compass Lexecon Client Wins Dismissal of J&J Subsidiary Bankruptcy
-
Latest cases
Compass Lexecon Client Co-Diagnostics Granted Motion for Summary Judgment in Securities Class Action
Court Relies on the Testimony of Senior Consultant Allen Ferrell
-
Latest cases
Compass Lexecon Client Desktop Metal Prevails in Broken Deal Litigation
-
Latest cases
Rio Tinto completes $6.7 billion acquisition of Arcadium Lithium
-
Latest cases
Report on electricity market design to support the development of flexibility in EU power systems - an analysis of best international practices
Showing 1–16 of 56 results
-
03 Feb 2025
Compass Lexecon experts Dennis Carlton, Anindya Ghose, and John List submitted testimony on the merits of plaintiffs’ antitrust claims on behalf of Meta. -
01 Oct 2024
This case involved a securities class action on behalf of purchasers of Bed Bath & Beyond stock and call options (Plaintiffs). Plaintiffs claimed that Mr. Cohen, an investor in Bed Bath & Beyond… -
03 Apr 2024
Compass Lexecon’s client Express Scripts defeated a motion for certification of putative classes of direct and indirect purchasers of the specialty drug Acthar. -
18 Dec 2023
On December 15, 2023, US District Judge J. Paul Oetken denied certification for a class of investors (plaintiffs) that claimed that major investment banks (defendants) conspired to boycott… -
15 Nov 2023
In early 2021, several stocks including GameStop Corp. (GME) and AMC Entertainment Holdings Inc. (AMC) experienced unexpected increases in prices and volatility, reaching dramatically higher… -
26 Oct 2022
On June 2, 2022, the US District Court for the Western District of New York ruled in favor of Compass Lexecon’s client Fisher-Price, denying class certification for damages to plaintiffs in a… -
03 Oct 2022
Plaintiffs sued on behalf of themselves and a putative class of investors who bought or sold futures contracts based on the Korean KOSPI 200 stock index during overnight trading in 2012. The… -
09 Aug 2021
Compass Lexecon Senior Consultant Dr. Janusz Ordover Cited Favorably in Class Certification Order; Plaintiff’s Expert Excluded under Daubert -
08 Jul 2020
Compass Lexecon experts provided analysis in two recent and successful outcomes in consumer class action cases alleging product defects. -
27 Jan 2019
Plaintiffs in In re: Bearings Cases (part of In re Automotive Parts Antitrust Litigation) alleged that manufacturers of steel ball and roller bearings for automotive and industrial use conspired… -
U.S. District Judge Jesse Furman approved the Plan of Distribution for the $408.5 million settlement in the ISDAfix Manipulation case, in which Plaintiffs allege that Defendants manipulated the…
-
In the sprawling LIBOR-Based Financial Instruments Antitrust Litigation matters, Plaintiffs sought certification of three separate classes: (i) traders of Eurodollar futures and options on…
-
14 Feb 2018
On January 11, 2018, the Intermediate People's Court in Shenzhen, China entered a ruling in favor of Compass Lexecon client Huawei Technologies Co., Ltd., a leading smartphone manufacturer, in a… -
-
-
28 Aug 2017
On August 28, 2017, the District Court in this case denied Plaintiffs’ motion to certify a class of direct purchasers of Cephalon’s branded drug Provigil.
Our professionals
Compass Lexecon’s staff includes more than 850 employees, including professional consultants, analysts, and practice support personnel that span 25 offices across the globe.
